PANEL DISCUSSION: A new framework for equity: Medical communications’ role in addressing health disparities

To address urgent health disparities, pharma needs to raise HCP awareness of minority patients’ barriers to healthcare, capture the right data to enable informed decision-making, and pinpoint where support is needed most. In partnership with Reuters, join experts from AstraZeneca, Johnson & Johnson, and Pfizer for a panel discussion hosted by HCG to gain key learnings including:
Discover why health disparities and inequities should matter to the medical communications industry, and the role we all can play in addressing inequity
Use data to identify health disparities, including access to healthcare, standard of treatments and care, and uneven health outcomes
Deliver omnichannel education to raise awareness of health disparities among HCPs and better support those working in underserved patient communities
Advocate for wider industry conversations around health inequities and identify solutions that will enable improved outcomes for minority groups

60 minute video

Presenters/Moderators

Matt D’Auria
CEO
Ruthline Laylor
Executive Director, Medical & Scientific Services, DEI Council
Victoria Malek
Associate Director, Global Market Access & Value Evidence
Luke Cole
SVP Digital Strategy

More Information

The Collective Intelligence Webinars leverage the global expertise of the Healthcare Consultancy Group (HCG) to provide leading professionals across pharma and biotech with thought-leadership examples of future thinking, collaboration, and communication excellence.

HCG is a global leader in medical communications, comprising 7 interconnected agencies with distinct personalities and complementary skills.

The depth of our expertise allows us to configure custom solutions to meet your scientific, regulatory, and digital needs. Discrete offices and robust processes ensure the confidentiality of your data and programs.

We give your programs the profile they deserve by building your team with you in mind.